These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8585907)

  • 1. Pathogenesis of renal cysts in dominantly inherited polycystic kidney disease.
    Grantham JJ
    Contrib Nephrol; 1995; 115():16-9. PubMed ID: 8585907
    [No Abstract]   [Full Text] [Related]  

  • 2. Filling in the matrix of kidney disease.
    Bacallao R
    Nat Med; 1995 Apr; 1(4):305-6. PubMed ID: 7585058
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormalities in extracellular matrix regulation in autosomal dominant polycystic kidney disease.
    Wilson PD; Norman JT; Kuo NT; Burrow CR
    Contrib Nephrol; 1996; 118():126-34. PubMed ID: 8744049
    [No Abstract]   [Full Text] [Related]  

  • 4. New insights into the molecular pathophysiology of polycystic kidney disease.
    Murcia NS; Sweeney WE; Avner ED
    Kidney Int; 1999 Apr; 55(4):1187-97. PubMed ID: 10200981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular cell and matrix changes in renal cystic disease.
    Carone FA; Kanwar Y
    Contrib Nephrol; 1993; 101():1-6. PubMed ID: 8467659
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the matrix in autosomal dominant polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar Y
    Ren Fail; 1998 Mar; 20(2):181-9. PubMed ID: 9574442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix abnormality may be responsible for cyst development.
    Bellinghieri G; Magaudda L; Santoro D; Esposito M; Pergolizzi S; Vaccaro M; Savica V
    Contrib Nephrol; 1997; 122():38-44. PubMed ID: 9399036
    [No Abstract]   [Full Text] [Related]  

  • 8. Polycystic kidney disease: huge kidneys, huge problems, huge progress.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 1997; 108():165-70; discussion 170-2. PubMed ID: 9108675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of autosomal dominant polycystic kidney disease: recent developments.
    Grantham JJ
    Contrib Nephrol; 1997; 122():1-9. PubMed ID: 9399029
    [No Abstract]   [Full Text] [Related]  

  • 10. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.
    Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE
    Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.
    Le NH; van der Wal A; van der Bent P; Lantinga-van Leeuwen IS; Breuning MH; van Dam H; de Heer E; Peters DJ
    J Am Soc Nephrol; 2005 Sep; 16(9):2724-31. PubMed ID: 16049073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.
    Wang X; Harris PC; Somlo S; Batlle D; Torres VE
    Nephrol Dial Transplant; 2009 Feb; 24(2):526-34. PubMed ID: 18826972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1.
    Huang CY; Ho MC; Lee JJ; Hwang DY; Ko HW; Cheng YC; Hsu YH; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Oct; 24():139-143. PubMed ID: 29034881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances.
    Grantham JJ
    Am J Kidney Dis; 1996 Dec; 28(6):788-803. PubMed ID: 8957030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by TGF-beta and bFGF of ECM expression by PKD cells 'in culture'.
    Altieri P; Caridi G; Ghiggeri GM; Garberi A; Ginevri F; Perfumo F; Gusmano R
    Contrib Nephrol; 1995; 115():122-6. PubMed ID: 8585898
    [No Abstract]   [Full Text] [Related]  

  • 16. Cystic changes of breast in a family with autosomal dominant polycystic kidney disease.
    Maleki D; Ghafari A
    Iran J Kidney Dis; 2009 Oct; 3(4):246-8. PubMed ID: 19841531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant polycystic kidney disease: cellular and molecular mechanisms of cyst formation.
    Wilson PD; Burrow CR
    Adv Nephrol Necker Hosp; 1992; 21():125-42. PubMed ID: 1566642
    [No Abstract]   [Full Text] [Related]  

  • 18. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
    Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
    Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
    Saigusa T; Bell PD
    Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.